Calendar

Apr-2014
M T W T F S S
21 22 23 24 25 26 27
Economic Events
list Leading Indicators
list Chicago Fed Nat Activity Index
Results
list Hind.Zinc | LIC Housing Fin. | Mindtree
IPO
list Issue Opening : Wonderla Holiday
listNew Listing : Women's Next
 

Dr. Reddy’s Laboratories launches Olanzapine Tablets

India Infoline News Service/ 08:34 , Apr 25, 2012

The ZYPREXA Tablets brand and generic had combined U.S. sales of approximately $3.28 billion for the most recent twelve months ending January 2012 according to IMS Health.

Dr. Reddy’s Laboratories announced today that it has launched Olanzapine Tablets (2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg), a bioequivalent generic version of ZYPREXA Tablets in the US market on April 23, 2012 following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy’s ANDA for Olanzapine Tablets.

Dr. Reddy’s Olanzapine Tablets in 20 mg had been awarded a 180-day period of marketing exclusivity in the U.S. on October 26, 2011 which was commercialized through a commercial, manufacture and supply agreement with Teva Pharmaceutical Industries Ltd.

The ZYPREXA Tablets brand and generic had combined U.S. sales of approximately $3.28 billion for the most recent twelve months ending January 2012 according to IMS Health.

Dr. Reddy’s Olanzapine Tablets in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg and 20 mg strengths are available in 30 and 500 count bottles.

 



Rate This Article Rate 1 Rate 2 Rate 3 Rate 4 Rate 5

Recent News Videos